Under the Radar Stocks Showing Strength as Hidden Growth Opportunities Emerge

 BullPower
 
  BullPower
 
Follow  Message
 
 
 
BullPower charges through the market, spotlighting analyst upgrades and downgrades that signal key opportunities. With sharp insights and a bullish edge, BullBoost guides investors to smarter, profit-driven decisions.
 

•  22 Nov 2025
 

•   NBTX  
   
  0.00%
•   TYGO  
   
  0.00%

$NBTX sits at the top of this category. Nanobiotix, a biotechnology company in the Health Care sector, has a market cap of around $1.04B and continues to advance its oncology technology platform while keeping a relatively low trading profile with just 28K shares moving on the day versus an average of nearly 99K. The stock trades at 20.93, holding above both its 20-day and 50-day moving averages at 21.59 and 18.24, reflecting a steady uptrend supported by an RSI of 51.61. Its recent participation in the Jefferies London Healthcare Conference reinforces growing institutional interest. Momentum traders will notice that while it isn’t exploding in volume, strength above its moving averages and increasing visibility in the biotech community point to emerging catalysts rather than fading ones. The risk, as always with mid-cap biotech, lies in clinical milestones and the sensitivity to newsflow, but the current trend remains constructive.

$TYGO tells a different story, but one that fits the theme of overlooked growth. Tigo Energy, operating in the Technology sector within Semiconductors, carries a market cap of just 125M yet saw an unusual spike in volume to 4.5M shares compared to an average of 532K. That type of divergence often signals that someone is paying attention even if the broader market isn’t. Trading at 1.78, the stock is hovering below its 20-day moving average of 2.17 but still above its 50-day at 2.11, creating an interesting dynamic where the technical picture leans neutral while sentiment looks increasingly optimistic. Analyst support is meaningful for a small-cap solar name: Craig-Hallum and Roth MKM both reiterated Buy ratings in early November, a rare wave of coverage for a company this size. The RSI at 39.21 reflects a market that is cautious but far from broken, and the stock remains in a sideways trend that could resolve higher if solar-related catalysts strengthen. The risk here comes from its micro-cap profile and sector volatility, which can quickly amplify moves in either direction.

Together, these names represent two sides of the under-the-radar universe: a fundamentally advancing biotech with a mature trend and a small solar-tech player experiencing a surge in analyst attention yet still trading like a niche idea.

$NBTX looks like the more attractive near-term opportunity due to its stronger technical structure and clearer upward momentum.

$TYGO could offer outsized upside if sector sentiment shifts and recently renewed analyst conviction draws broader interest.

View All Headlines